Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk The CARMELINA Randomized Clinical Trial

Erstveröffentlichung
2019Authors
Rosenstock, Julio
Perkovic, Vlado
Johansen, Odd Erik
Cooper, Mark E.
Kahn, Steven E.
Wissenschaftlicher Artikel
Published in
Journal of the American Medical Association ; 321 (2019), 1. - S. 69-79. - ISSN 0098-7484. - eISSN 1538-3598
Link to publication
https://dx.doi.org/10.1001/jama.2018.18269Institutions
UKU. Klinik für Innere Medizin IISubject headings
[DDC subject group]: DDC 610 / Medicine & healthMetadata
Show full item recordThis could also interest you:
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
Klionsky, Daniel J. et al. (2021)Wissenschaftlicher Artikel
-
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight NCD Risk Factor Collaboration (NCD-RisC)
Iurilli, Maria L. C. et al. (2021)Wissenschaftlicher Artikel
-
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Bonaca, Marc P. et al. (2015)Wissenschaftlicher Artikel